171 related articles for article (PubMed ID: 31047039)
1. Next-generation Sequencing in the Management of Gastric and Esophageal Cancers.
Rubinstein JC; Nicolson NG; Ahuja N
Surg Clin North Am; 2019 Jun; 99(3):511-527. PubMed ID: 31047039
[TBL] [Abstract][Full Text] [Related]
2. What Will We Expect From Novel Therapies to Esophageal and Gastric Malignancies?
De Mello RA; Castelo-Branco L; Castelo-Branco P; Pozza DH; Vermeulen L; Palacio S; Salzberg M; Lockhart AC
Am Soc Clin Oncol Educ Book; 2018 May; 38():249-261. PubMed ID: 30231398
[TBL] [Abstract][Full Text] [Related]
3. DNA Genome Sequencing in Esophageal Adenocarcinoma.
Pillai S; Gopalan V; Lam AK
Methods Mol Biol; 2018; 1756():231-246. PubMed ID: 29600374
[TBL] [Abstract][Full Text] [Related]
4. Early diagnosis and management of esophageal and gastric cancer.
Lang GD; Konda VJ
Minerva Gastroenterol Dietol; 2013 Dec; 59(4):357-76. PubMed ID: 24212354
[TBL] [Abstract][Full Text] [Related]
5. Integrated genomic characterization of oesophageal carcinoma.
; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
Nature; 2017 Jan; 541(7636):169-175. PubMed ID: 28052061
[TBL] [Abstract][Full Text] [Related]
6. Oligometastatic Gastroesophageal Adenocarcinoma: Molecular Pathophysiology and Current Therapeutic Approach.
Jung JO; Nienhüser H; Schleussner N; Schmidt T
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32023907
[TBL] [Abstract][Full Text] [Related]
7. Oesophageal adenocarcinoma and gastric cancer: should we mind the gap?
Hayakawa Y; Sethi N; Sepulveda AR; Bass AJ; Wang TC
Nat Rev Cancer; 2016 Apr; 16(5):305-18. PubMed ID: 27112208
[TBL] [Abstract][Full Text] [Related]
8. Genomic Alterations and Targeted Therapy in Gastric and Esophageal Adenocarcinoma.
Pectasides E
Clin Ther; 2016 Jul; 38(7):1589-99. PubMed ID: 27041412
[TBL] [Abstract][Full Text] [Related]
9. Genomic characterization of esophageal squamous cell carcinoma: Insights from next-generation sequencing.
Sasaki Y; Tamura M; Koyama R; Nakagaki T; Adachi Y; Tokino T
World J Gastroenterol; 2016 Feb; 22(7):2284-93. PubMed ID: 26900290
[TBL] [Abstract][Full Text] [Related]
10. Whole-genome reconstruction and mutational signatures in gastric cancer.
Nagarajan N; Bertrand D; Hillmer AM; Zang ZJ; Yao F; Jacques PÉ; Teo AS; Cutcutache I; Zhang Z; Lee WH; Sia YY; Gao S; Ariyaratne PN; Ho A; Woo XY; Veeravali L; Ong CK; Deng N; Desai KV; Khor CC; Hibberd ML; Shahab A; Rao J; Wu M; Teh M; Zhu F; Chin SY; Pang B; So JB; Bourque G; Soong R; Sung WK; Tean Teh B; Rozen S; Ruan X; Yeoh KG; Tan PB; Ruan Y
Genome Biol; 2012 Dec; 13(12):R115. PubMed ID: 23237666
[TBL] [Abstract][Full Text] [Related]
11. Molecular Diagnostics in Esophageal and Gastric Neoplasms: 2018 Update.
Zulfiqar M; Bluth MH; Bhalla A
Clin Lab Med; 2018 Jun; 38(2):357-365. PubMed ID: 29776635
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive Genomic Profiling of Advanced Esophageal Squamous Cell Carcinomas and Esophageal Adenocarcinomas Reveals Similarities and Differences.
Wang K; Johnson A; Ali SM; Klempner SJ; Bekaii-Saab T; Vacirca JL; Khaira D; Yelensky R; Chmielecki J; Elvin JA; Lipson D; Miller VA; Stephens PJ; Ross JS
Oncologist; 2015 Oct; 20(10):1132-9. PubMed ID: 26336083
[TBL] [Abstract][Full Text] [Related]
13. The impact of recent next generation sequencing and the need for a new classification in gastric cancer.
Businello G; Galuppini F; Fassan M
Best Pract Res Clin Gastroenterol; 2021; 50-51():101730. PubMed ID: 33975684
[TBL] [Abstract][Full Text] [Related]
14. Mutation Profiling of Clinically Advanced Cancers Using Next-Generation Sequencing for Targeted Therapy: A Lifespan Experience.
Friedman K; Resnick MB; Safran H
R I Med J (2013); 2015 Oct; 98(10):16-20. PubMed ID: 26422540
[TBL] [Abstract][Full Text] [Related]
15. Microarray and next-generation sequencing to analyse gastric cancer.
Dang Y; Wang YC; Huang QJ
Asian Pac J Cancer Prev; 2014; 15(19):8033-9. PubMed ID: 25338980
[TBL] [Abstract][Full Text] [Related]
16. Genomic and epigenomic heterogeneity in molecular subtypes of gastric cancer.
Lim B; Kim JH; Kim M; Kim SY
World J Gastroenterol; 2016 Jan; 22(3):1190-201. PubMed ID: 26811657
[TBL] [Abstract][Full Text] [Related]
17. Genomics Study of Gastric Cancer and Its Molecular Subtypes.
Yuen ST; Leung SY
Adv Exp Med Biol; 2016; 908():419-39. PubMed ID: 27573784
[TBL] [Abstract][Full Text] [Related]
18. Single disease entity for both chromosomal instable subtype gastric adenocarcinoma and esophageal adenocarcinoma.
Huang Q
J Dig Dis; 2017 Jun; 18(6):319-322. PubMed ID: 28509354
[TBL] [Abstract][Full Text] [Related]
19. Differences in the molecular biology of adenocarcinoma of the esophagus, gastric cardia, and upper gastric third.
Lehmann K; Schneider PM
Recent Results Cancer Res; 2010; 182():65-72. PubMed ID: 20676871
[TBL] [Abstract][Full Text] [Related]
20. From Tumor Immunology to Immunotherapy in Gastric and Esophageal Cancer.
Vrána D; Matzenauer M; Neoral Č; Aujeský R; Vrba R; Melichar B; Rušarová N; Bartoušková M; Jankowski J
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30577521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
